Rankings
▼
Calendar
MNKD Q2 2025 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$77M
+5.7% YoY
Gross Profit
$56M
73.1% margin
Operating Income
$5M
6.9% margin
Net Income
$668,000
0.9% margin
EPS (Diluted)
$0.00
QoQ Revenue Growth
-2.3%
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$8M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$412M
Total Liabilities
$467M
Stockholders' Equity
-$55M
Cash & Equivalents
$57M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$77M
$72M
+5.7%
Gross Profit
$56M
$52M
+7.6%
Operating Income
$5M
$17M
-68.1%
Net Income
$668,000
-$2M
+133.2%
Revenue Segments
Product Revenue
$45M
58%
Royalty
$31M
41%
Service
$621,000
1%
← FY 2025
All Quarters
Q3 2025 →